P‐tau181 testing was negative (0.67 pg/mL), whereas NfL was elevated to 9.13 pg/mL (reference < 4.61), suggesting CBS was due to a 4R‐tauopathy, in particular corticobasal degeneration (CBD). The gene discussed is NEFL; the disease is corticobasal degeneration disorder.